Is GHRS or GNLX more undervalued in 2026?

CirclFi compares GH Research PLC (GHRS) and Genelux Corporation (GNLX) using 13 institutional-grade valuation models. GHRS has a Quality of Company score of 4.4/10 while GNLX scores 5.1/10.

Which is a better buy — GHRS or GNLX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do GHRS and GNLX valuations compare?

GHRS at $23.99 and GNLX at $3.05 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

GHRS vs GNLX Valuation Comparison 2026 — Intrinsic Value Analysis

GHRS

Pharmaceutical Preparations

GH Research PLC

Quality

4.4

out of 10

Value Trap

SAFE

Price

$23.99

Last close

Models

7/13

Active

GNLX

Pharmaceutical Preparations

Genelux Corporation

Quality

5.1

out of 10

Value Trap

LOW

Price

$3.05

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	GHRS Fair Value	GHRS Upside	GNLX Fair Value	GNLX Upside
Bayesian DCF	Intrinsic	$3.64	-84.8%	$0.87	-71.4%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$1.41	-94.1%	$0.33	-89.1%
Dynamic NAV	Asset-Based	$2.62	-89.1%	$1.26	-58.6%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for GHRS vs GNLX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

GHRS vs GNLX — Which Stock Is More Undervalued?

GNLX scores higher with a 5.1/10 quality rating vs GHRS's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing GH Research PLC (GHRS) and Genelux Corporation (GNLX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

GHRS currently trades at $23.99 with a QOC of 4.4/10, while GNLX trades at $3.05 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).